Press "Enter" to skip to content

WHO halts hydroxychloroquine and combination of HIV drug trials among hospitalised Covid-19 patients

The World Health Organisation on Saturday has halted its trials of the malaria drug hydroxychloroquine and mixture of HIV drug lopinavir/ritonavir for the therapy of hospitalised Covid-19 sufferers after they failed to scale back the loss of life charge, Al Jazeera reported.

“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised Covid-19 patients when compared to the standard of care. Solidarity trial investigators will interrupt the trials with immediate effect,” the WHO was quoted as saying in an announcement.

The WHO has added that this choice will now have an effect on the opposite research the place the medication are getting used for non-hospitalised or as prophylaxis.

Meanwhile, the WHO has reported a complete of 212,326 new instances of coronavirus globally in 24 hours.

The company additional said that 5,134 deaths have been reported in previous 24 hours, taking the overall toll to 523,011.

The WHO had declared the Covid-19 outbreak a pandemic on March 11.

Source hyperlink

More from WorldMore posts in World »
  • बेलारूस के विपक्षी उम्मीदवार, कुछ यूरोपीय संघ के अधिकारी, राष्ट्रपति चुनाव की समीक्षा के लिए बुलाओ | सीबीसी न्यूज
  • बेलारूस में विरोध प्रदर्शन, अलेक्जेंडर लुकाशेंको ने विदेशियों को दोषी ठहराया
  • बेरूत विस्फोट जांच में शामिल होने के लिए एफबीआई, लेबनान को ‘खाली वादे’ खत्म करने होंगे: अमेरिकी दूत
  • ट्रम्प-रूस जांच मूल के परिणामस्वरूप एफबीआई वकील को आरोपित किया जाना चाहिए सीबीसी न्यूज
  • कमला हैरिस जो बिडेन के अभियान में ऊर्जा, डॉलर और बहुत कुछ ला रही है

Be First to Comment

    Leave a Reply

    %d bloggers like this: